Sign In
Buy UBS
$53.57
+0.110 (+0.206%)
At Close: Aug 05, 2026
Reviva to Participate in the UBS Global Healthcare Conference
08:00am, Thursday, 31'st Oct 2024
CUPERTINO, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies
NaaS Technology CFO to Headline UBS Charging Industry Call Series
08:00am, Thursday, 31'st Oct 2024
BEIJING , Oct. 31, 2024 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that Mr. Steven Sim,
UBS Global Wealth Management: market still 'supportive for equities', but not overpriced
03:46am, Thursday, 31'st Oct 2024
Brenda O'Connor Juanas expects solid earnings in the tech space, adding that the macro environment remains supportive for equities, and financials and utilities look attractive from a valuation standp
Apple lacking ‘killer AI use case' to drive iPhone demand - UBS
02:37pm, Wednesday, 30'th Oct 2024
Apple Inc (NASDAQ:AAPL, ETR:APC)'s flagship artificial intelligence (AI) launch has underwhelmed, leaving the technology giant in need of a “killer” use case to drive iPhone demand, UBS analysts s
UBS Group Q3 Earnings & Revenues Increase Y/Y, Expenses Decline
01:31pm, Wednesday, 30'th Oct 2024
UBS' third-quarter 2024 results reflect strong growth in the Global Wealth Management, Asset Management and Investment Bank divisions.
UBS Group AG (UBS) Q3 2024 Earnings Call Transcript
08:45am, Wednesday, 30'th Oct 2024
UBS Group AG (NYSE:UBS ) Q3 2024 Earnings Conference Call October 30, 2024 4:00 AM ET Company Participants Sarah Mackey – Head, IR Sergio Ermotti - Group CEO Todd Tuckner - Group CFO Conference Call
UBS (UBS) Tops Q3 Earnings and Revenue Estimates
08:05am, Wednesday, 30'th Oct 2024
UBS (UBS) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to loss of $0.24 per share a year ago.
Inspire Medical Systems, Inc. to Present at UBS Global Healthcare Conference
08:00am, Wednesday, 30'th Oct 2024
MINNEAPOLIS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima
UBS remains in discussion with Swiss govt over capital plans, CEO says
06:56am, Wednesday, 30'th Oct 2024
UBS remains in "technical discussions" with the Swiss government about its plans for the bank to hold more capital but is yet to receive feedback, CEO Sergio Ermotti said on Wednesday.
Stocks have rarely been this expensive versus bonds. Now, UBS expects that to change.
06:43am, Wednesday, 30'th Oct 2024
Stocks are now expected to weaken versus bonds, argue UBS strategists.
U.S. election won't be an 'uneventful event' for global markets, UBS chief says
06:26am, Wednesday, 30'th Oct 2024
"We do expect, no matter who wins and the outcome, we do expect some market movements. And it remains to be seen how investors will react," Ermotti added.
UBS Ermotti: Brace For Volatility as Markets Expect Trump Win
06:20am, Wednesday, 30'th Oct 2024
Investors around the world are betting on a Donald Trump victory in US elections next week, but whatever the outcome more volatility is in store, UBS CEO Sergio Ermotti said. Read more: https://ww
UBS smashes forecasts with bumper profit, warns of volatility around U.S. elections
04:48am, Wednesday, 30'th Oct 2024
The Swiss bank's profits were boosted by the ongoing integration of wealth management accounts previously run by its main rival Credit Suisse
UBS CEO Sergio Ermotti on Earnings and Why He's Wary of US Election Risks
04:37am, Wednesday, 30'th Oct 2024
UBS CEO Sergio Ermotti discusses the integration of Credit Suisse, the US election and the outlook for inflation. He also comments on share buybacks, capital requirements and the prospects for UBS's A
U.S. election will not be an 'uneventful event' for markets, UBS chief Sergio Ermotti warns
04:12am, Wednesday, 30'th Oct 2024
UBS CEO Sergio Ermotti discusses the market outlook for the fourth-quarter, from macroeconomic and geopolitical uncertainty to the impact of the upcoming U.S. elections.
